ACS Nano,
Journal Year:
2024,
Volume and Issue:
19(2), P. 2591 - 2614
Published: Dec. 26, 2024
Neural
stem
cell
(NSCs)
transplantation
is
a
promising
therapeutic
strategy
for
spinal
cord
injury
(SCI),
but
its
efficacy
greatly
limited
by
the
local
inhibitory
microenvironment.
In
this
study,
based
on
l-arginine
(l-Arg)-loaded
mesoporous
hollow
cerium
oxide
(AhCeO2)
nanospheres,
we
constructed
an
injectable
composite
hydrogel
(AhCeO2-Gel)
with
microenvironment
modulation
capability.
AhCeO2-Gel
protected
NSCs
from
oxidative
damage
eliminating
excess
reactive
oxygen
species
while
continuously
delivering
Nitric
Oxide
to
lesion
of
SCI
in
pathological
microenvironment,
latter
which
effectively
promoted
neural
differentiation
NSCs.
The
process
was
confirmed
be
closely
related
up-regulation
cAMP-PKA
pathway
after
NO-induced
calcium
ion
influx.
addition,
significantly
polarization
microglia
toward
M2
subtype
as
well
enhanced
regeneration
nerves
and
myelinated
axons.
prepared
bioactive
system
also
efficiently
facilitated
integration
transplanted
host
circuits,
replenished
damaged
neurons,
alleviated
neuroinflammation,
inhibited
glial
scar
formation,
thus
accelerating
recovery
motor
function
rats.
Therefore,
synergized
has
great
potential
integrated
treat
comprehensively
reversing
Gels,
Journal Year:
2024,
Volume and Issue:
10(3), P. 190 - 190
Published: March 9, 2024
The
repair
of
nervous
tissue
is
a
critical
research
field
in
engineering
because
the
degenerative
process
injured
system.
In
this
review,
we
summarize
progress
injectable
hydrogels
using
vitro
and
vivo
studies
for
regeneration
tissue.
Traditional
treatments
have
not
been
favorable
patients,
as
they
are
invasive
inefficient;
therefore,
promising
treatment
damaged
This
review
will
contribute
to
better
understanding
potential
scaffolds
drug
delivery
system
neural
applications.
Macromolecular Bioscience,
Journal Year:
2024,
Volume and Issue:
24(5)
Published: Jan. 15, 2024
Abstract
Spinal
cord
injuries
are
very
common
worldwide,
leading
to
permanent
nerve
function
loss
with
devastating
effects
in
the
affected
patients.
The
challenges
and
inadequate
results
current
clinical
treatments
scientists
innovative
neural
regenerative
research.
Advances
nanoscience
tissue
engineering
have
opened
new
avenues
for
spinal
injury
(SCI)
treatment.
In
order
designed
guidance
conduit
(NGC)
be
functionally
useful,
it
must
ideal
scaffold
properties
topographic
features
that
promote
linear
orientation
of
damaged
axons.
this
study,
is
aimed
develop
channeled
polycaprolactone
(PCL)/Poly‐D,L‐lactic‐co‐glycolic
acid
(PLGA)
hybrid
film
scaffolds,
modify
their
surfaces
by
IKVAV
pentapeptide/gold
nanoparticles
(AuNPs)
or
polypyrrole
(PPy)
investigate
behavior
motor
neurons
on
vitro
under
static/bioreactor
conditions.
Their
potential
regeneration
after
implantation
into
rat
SCI
shaping
scaffolds
modified
factors
a
tubular
form
also
examined.
It
shown
groups
decorated
AuNPs
highly
neurite
bioreactor
conditions
developed
optimal
NGC
(PCL/PLGA
G1‐IKVAV/BDNF/NGF‐AuNP
50
)
regenerates
SCI.
indicate
can
an
candidate
regeneration.
Regenerative Therapy,
Journal Year:
2024,
Volume and Issue:
26, P. 508 - 519
Published: June 1, 2024
Spinal
cord
injury
(SCI)
has
limited
treatment
options
for
regaining
function.
Adipose-derived
stem
cells
(ADSCs)
show
promise
owing
to
their
ability
differentiate
into
multiple
cell
types,
promote
nerve
survival,
and
modulate
inflammation.
This
review
explores
ADSC
therapy
SCI,
focusing
on
its
potential
improving
function,
preclinical
early
clinical
trial
progress,
challenges,
future
directions.
Preclinical
studies
have
demonstrated
transplantation's
effectiveness
in
promoting
functional
recovery,
reducing
cavity
formation,
enhancing
regrowth
myelin
repair.
To
improve
efficacy,
strategies
including
genetic
modification
combination
with
rehabilitation
are
being
explored.
Early
trials
shown
safety
feasibility,
some
suggesting
motor
sensory
function
improvements.
Challenges
remain
translation,
optimizing
survival
delivery,
determining
dosing,
addressing
tumor
formation
risks,
establishing
standardized
protocols.
Future
research
should
focus
overcoming
these
challenges
exploring
the
combining
other
treatments,
medication.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology,
Journal Year:
2024,
Volume and Issue:
16(3)
Published: May 1, 2024
Abstract
The
extracellular
matrix
(ECM)
is
a
dynamic
and
complex
network
of
proteins
molecules
that
surrounds
cells
tissues
in
the
nervous
system
orchestrates
myriad
biological
functions.
This
review
carefully
examines
diverse
interactions
between
ECM,
as
well
transformative
chemical
physical
changes
ECM
undergoes
during
neural
development,
aging,
disease.
These
transformations
play
pivotal
role
shaping
tissue
morphogenesis
activity,
thereby
influencing
functionality
central
(CNS).
In
our
comprehensive
review,
we
describe
behaviors
CNS
different
physiological
pathological
scenarios
explore
unique
properties
make
ECM‐based
strategies
attractive
for
repair
regeneration.
Addressing
challenges
scalability,
variability,
integration
with
host
tissues,
how
advanced
natural,
synthetic,
combinatorial
approaches
enhance
biocompatibility,
mechanical
properties,
functional
recovery.
Overall,
this
highlights
potential
decellularized
powerful
tool
modeling
regenerative
purposes
sets
stage
future
research
exciting
field.
article
categorized
under:
Implantable
Materials
Surgical
Technologies
>
Nanotechnology
Tissue
Repair
Replacement
Therapeutic
Approaches
Drug
Discovery
Nanomedicine
Neurological
Disease
Nanomaterials
Implants
Frontiers in Cellular Neuroscience,
Journal Year:
2024,
Volume and Issue:
18
Published: May 9, 2024
Spinal
cord
injury
(SCI)
disrupts
nerve
pathways
and
affects
sensory,
motor,
autonomic
function.
There
is
currently
no
effective
treatment
for
SCI.
SCI
occurs
within
three
temporal
periods:
acute,
subacute,
chronic.
In
each
period
there
are
different
alterations
in
the
cells,
inflammatory
factors,
signaling
spinal
cord.
Many
biomaterials
have
been
investigated
of
SCI,
including
hydrogels
fiber
scaffolds,
some
progress
has
made
using
multiple
materials.
However,
limitations
when
individual
treatment,
these
can
be
significantly
improved
by
combining
treatments
with
stem
cells.
order
to
better
understand
investigate
new
strategies
its
several
combination
therapies
that
include
materials
combined
drugs,
cytokines,
etc.
summarized
current
review.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: June 27, 2024
Severe
spinal
cord
injuries
(SCI)
lead
to
loss
of
functional
activity
the
body
below
injury
site,
affect
a
person’s
ability
self-care
and
have
direct
impact
on
performance.
Due
structural
features
role
in
body,
consequences
SCI
cannot
be
completely
overcome
at
expense
endogenous
regenerative
potential
and,
developing
over
time,
severe
complications
years
after
injury.
Thus,
primary
task
this
type
treatment
is
create
artificial
conditions
for
growth
damaged
nerve
fibers
through
area
SCI.
Solving
problem
possible
using
tissue
neuroengineering
involving
technology
replacing
natural
environment
with
synthetic
matrices
(for
example,
hydrogels)
combination
stem
cells,
particular,
neural/progenitor
cells
(NSPCs).
This
approach
can
provide
maximum
stimulation
support
axons
neurons
their
myelination.
In
review,
we
consider
currently
available
options
improving
condition
(use
NSC
transplantation
or/and
replacement
matrix,
specifically
hydrogel).
We
emphasise
expediency
effectiveness
hydrogel
matrix
+
NSCs
complex
system
used
reconstruction
Since
such
(a
engineering
cell
therapy),
our
opinion,
allows
not
only
creation
supporting
regeneration
or
mechanical
cord,
but
also
strengthen
regeneration,
prevent
spread
inflammatory
process,
promote
restoration
lost
reflex,
motor
sensory
functions
injured
cord.
Frontiers in Bioengineering and Biotechnology,
Journal Year:
2025,
Volume and Issue:
13
Published: April 23, 2025
Spinal
cord
injury
(SCI)
is
a
severe
condition
that
frequently
leads
to
permanent
disabilities
and
neurological
dysfunction.
Its
progression
driven
by
multifaceted
pathophysiology,
encompassing
direct
trauma,
secondary
cascades,
intricate
cellular
molecular
responses.
While
current
therapies
focus
on
alleviating
symptoms
restoring
functionality,
achieving
effective
neural
regeneration
in
the
spinal
continues
be
significant
challenge.
Hydrogels,
recognized
for
their
exceptional
biocompatibility,
conductivity,
injectability,
have
shown
great
potential
as
advanced
scaffolds
support
neuronal
axonal
regeneration.
Recently,
these
materials
attracted
interest
field
of
SCI
rehabilitation
research.
This
review
concludes
recent
progress
hydrogel-based
strategies
rehabilitation,
emphasizing
distinct
properties,
underlying
mechanisms,
integration
with
bioactive
molecules,
stem
cells,
complementary
biomaterials.
Hydrogels
foster
providing
tailored
microenvironment,
while
features
such
self-repair,
electrical
controlled
drug
release
significantly
enhance
therapeutic
experimental
models.
explores
hydrogel
technologies
applications,
underscoring
address
challenges
treatment
paving
way
future
clinical
implementation.
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(10), P. 2773 - 2773
Published: May 8, 2024
Spinal
cord
injury
is
a
complicated
medical
condition
both
from
the
clinician's
point
of
view
in
terms
management
and
patient's
perspective
unsatisfactory
recovery.
Depending
on
severity,
this
disorder
can
be
devastating
despite
rapid
appropriate
use
modern
imaging
techniques
convenient
surgical
spinal
decompression
stabilization.
In
context,
there
mandatory
need
for
novel
adjunctive
therapeutic
approaches
to
classical
treatments
improve
rehabilitation
chances
clinical
outcomes.
This
review
offers
new
original
therapies
targeting
microglia,
one
most
relevant
immune
cells
implicated
disorders.
The
first
part
manuscript
reviews
anatomical
pathophysiological
importance
blood-spinal
barrier
components,
including
role
microglia
post-acute
neuroinflammation.
Subsequently,
authors
present
emerging
based
modulation,
such
as
cytokines
modulators,
stem
cell,
microRNA,
nanoparticle-based
that
could
positively
impact
management.
Finally,
future
perspectives
challenges
are
also
highlighted
ongoing
trials
related
medications
microglia.
Biofabrication,
Journal Year:
2024,
Volume and Issue:
16(4), P. 045009 - 045009
Published: July 10, 2024
Abstract
Over
the
past
three
decades,
cell
therapy
development
has
fallen
short
of
expectations,
with
many
cellular
sources
demonstrating
a
‘Janus
effect’
and
raising
safety
concerns.
Extracellular
vesicles
(EVs),
supported
by
advanced
technologies,
present
promising
avenue
in
regenerative
medicine,
offering
benefits
such
as
immune
tolerance
avoidance
negative
aspects
associated
transplants.
Our
previous
research
showcased
enhanced
organized
subcutaneous
vascularization
using
three-dimensional
bioprinted
patches
containing
HUVEC-derived
EVs
immunodeficient
animal
models.
In
this
context,
stress
conditions
on
cells
origin
further
boosted
EVs’
neoangiogenic
potential.
Since
neovascularization
is
first
target
requiring
restoration,
study
aims
to
complement
our
work
employing
an
injectable
gelatin
methacrylate
(GelMA)
hydrogel
functionalized
pathological
condition
acute
myocardial
infarction.
This
bioactive
resulted
reduced
fibrosis,
improved
contractility,
promoted
angiogenesis,
showing
promise
countering
tissue
deterioration
addressing
vascular
deficits.
Moreover,
molecular
characterization
through
miRNome
proteomic
analyses
supports
their
potential
bio-additives
for
functionalization.
cell-free
approach
mitigates
rejection
oncogenic
risks,
innovative
therapeutic
advantages.